" class="no-js "lang="en-US"> Industry News Archives - Page 138 of 151 - Medtech Alert
Monday, October 20, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

Entos Raises $53 Million Series A Round Led by Coatue and Catalio

Entos, Inc (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology […]

Medable Opens New EMEA Headquarters in Dublin; Expands European Presence to Grow Market for Decentralized Clinical Trials

Medable Inc., the leading cloud platform for patient-centered drug development, today announced the first stage […]

Mammoth Scientific Launches $100 Million Venture Capital Fund

Mammoth™ Scientific, a health science and technology venture capital firm, announced the launch of a […]

Ada Expands its Global Leadership Team to Help Drive Company’s Rapid Growth

Ada, the global health company, today announces the appointment of digital transformation veterans Gülsah Wilke, […]

Lilly Announces Acquisition of Protomer Technologies

Eli Lilly and Company (NYSE: LLY) today announced the acquisition of Protomer Technologies (“Protomer”), a private […]

NHS Investment Boost to Ambulance Staff Numbers Ahead of Winter

Ambulance Trusts in England will be given an extra £55 million to boost staff numbers […]

‘Skin Snaps’ and Rapid Tests Among £20 Million NHS Push to Speed Cancer Diagnosis

‘Skin snaps’ and rapid tests for same day diagnosis are among a package of measures […]

Stem Cell Therapy Company Amniotics Raises SEK 60 Million

Amniotics AB (publ) (“Amniotics” or the “Company”), a stem cell therapy company has raised SEK60 million through […]

IW Capital Announces Investment in E-Pharmacy Platform SimplyMeds

IW Capital is proud to announce their investment in e-pharmacy company SimplyMeds, marking the first external investment in […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more